Cost-effectiveness, Human soluble insulin, Insulin aspart, Type 2 diabetes
Chinese Journal of New Drugs
No subscription
Erasmus School of Health Policy & Management (ESHPM)

Xu, Z.-R, Ji, Q.-H, Xu, F, & Ye, Q. (2014). Cost-effectiveness of insulin aspart and human soluble insulin for treatment of type 2 diabetes. Chinese Journal of New Drugs, 23(18), 2174–2179. Retrieved from

Additional Files
publisher's information